Search results for: rn

February 8th, 2011

Happy Birthday — Text4Baby Turns One!!!

By Sarah Colamarino, Vice President, Corporate Communications, Johnson & Johnson

As a mother, I have always been proud of our work to better the health of women and children around the world. Over the past 2 years, I had the opportunity to be deeply involved with text4baby, an initiative designed to deliver healthy pregnancy information to under resourced expectant mothers.

The idea was simple: leverage the reach of mobile phones to deliver important health information to new and expecting moms. The concept of text4baby was born at the National Healthy Mothers, Healthy Babies Coalition and quickly became a reality through an innovative platform from Voxiva, the essential backing of CTIA—The Wireless Foundation and the passionate support of the healthcare community across the country.

As David Borstein explained in a piece on today’s online version of the New York Times, helping to raise text4baby has been quite a journey. From the White House to public health clinics across the country, more than 400 partners adopted text4baby as their own. As the founding sponsor of text4baby, Johnson & Johnson salutes the efforts of every partner who helped text4baby reach more than 126,000 moms in just one year. I’ve seen their efforts firsthand at the grassroots level and they are truly moving.

Read More

July 16th, 2010

Preventing HIV Transmission in Newborns

From Anu Gupta, M.D., Director, Corporate Contributions, Johnson & Johnson

As I pulled out my suitcase to pack for the upcoming International AIDS Society conference in Vienna, Austria, I was reminded of the last time I used it. A month ago, I had traveled to Washington, D.C. to attend the Global Health Council Award Dinner. While I had been to the dinner before, this was a very special year because I had nominated mothers2mothers (m2m) for an award and they had won! 

As I sat with m2m founder Dr. Mitch Besser at the VIP table with luminaries in global health, I recalled my last visit to m2m in October 2006 to open a series of new sites in East London, South Africa, where Johnson & Johnson has had a manufacturing facility for more than 75 years. The mentor mothers I met on that trip, their stories, their songs and their struggles have stayed with me. 

It was no surprise to me that when Mitch went to the podium to accept the award, his speech was all about the mothers – the mentor mothers, all HIV-positive, who had recently delivered and gone through the process of taking antiretrovirals to prevent mother-to-child transmission, and the pregnant women, also all HIV-positive, whom the mentor mothers were actively empowering through words and by example to have healthy children and live healthier lives. 

Read More

July 1st, 2010

Collaboration is Key to Maternal and Newborn Health

From Paul Stoffels, Global Head, Pharmaceuticals Research & Development

Last week I was privileged to represent Johnson & Johnson at the Pacific Health Summit (PHS) – an annual gathering that convenes nearly 250 leaders in science, policy and industry to focus on issues of critical importance to global health. It is a unique event that connects decision makers to spark solutions in the quest for a healthier world.

This year’s theme was Maternal and Newborn Health. The idea is that caring for mothers and providing opportunities for better prenatal, newborn and childhood care can lead to a healthier, more productive world.

For many of us in the developed world, access to maternal and child care is a given. But for many mothers and children around the world, that’s not the case. According to a recent report, globally, 8.8 million children a year die before their fifth birthday, more than 40 percent of them during their first four weeks of life. At least two-thirds of all child deaths are preventable.

No theme could be more aligned with the work and values of Johnson & Johnson. Women and children have been at the heart of our core business for nearly 125 years.

Read More

March 28th, 2009

Turn Off, Take Action

By Mark Krajnak, Manager, Corporate Communications, Johnson & Johnson

going-green

Most people have heard about Earth Day, which was first celebrated on April 22, 1970 (a mere three days before I was born, in fact.), and will celebrated again in just a few weeks.

But how many people know about Earth Hour, a new global initiative is taking place today? Sponsored by the World Wildlife Fund (WWF), Earth Hour will take place at 8:30 p.m. your local time and encourages people to turn off their lights which organizers hope to capture as a vote that signals support for governments to take action against global warming.

Earth Hour began in Sydney, Australia, in 2007, when 2.2 million homes and businesses switched off their lights for one hour. Last year, there was a more of a global groundswell and in 2009, Earth Hour is being taken to the next level, with the goal of 1 billion people switching off their lights as part of a global vote.

Hearing that Johnson & Johnson intends to support this initiative as well
(by simply turning out all non-essential lighting for one hour at our offices and facilities) my family decided that we too are going to take part in this initiative.

Read More

March 20th, 2008

Learning to be a good patient

We tend to talk a lot about the rise of “consumerism” in health care today. People are taking more control over their personal health through on-line research, questioning of their physicians, information sharing with friends, and an increasing interest in wellness. Consumers are increasingly taking more command of their health and treatments.

One obstacle to consumerism is people’s own willingness and understanding of how they can best participate in their own health care. Health care blogger Dr. Rob offers some very interesting thoughts on what it “how to be a good patient” nowadays.
It’s especially helpful if you’re like me and have been raised by parents who think being a good patient means “just doing what the doctor tells you.” Enjoy.

P.S.
(hat tip to Kevin, M.D. for this one).

Read More

March 2nd, 2008

Going to California

By Marc

I’m lighting out for the territory on Monday for the Health 2.0 meeting in San Diego — and will hopefully arrive in time to join the reception we are hosting that evening.

I’m excited about the event, which will provide yet another opportunity to discuss how new online tools and approaches can be applied to healthcare. It’s pretty timely as last week Google unveiled its own offering to help people manage their personal health data and information. With it, they join Microsoft, who last year launched its Healthvault platform.

Despite the promise of these approaches, according to the WSJ, they both seem to face an uphill battle:

So far, consumers have been slow to make use of services that allow them to set up personal
health records, partly because of concerns about online privacy. Limiting the usefulness of these services, only a small percentage — 14% — of U.S. medical practices keep records electronically, according to the Department of Health and Human Services. The HHS is targeting 50% adoption by medical practitioners by 2014.

Once again, the question seems to be, if you build it, will they come? What’s intriguing about this week’s meeting is that Matthew and Indu hope to get users — patients and physicians — on stage to talk about what they are looking for from these tools.

Read More

November 21st, 2007

So… what’s with the ear horn?

Since I started blogging in June, I’ve been learning a lot about the art of conversation. While I’ve been trying to find my voice to offer perspective on stories, I’m also hearing a lot from people who either agree with or disagree with me. I often feel like I’ve just crashed a cocktail party — as I barge into some fascinating conversations that have been going on for a while without me, I sometimes find that I not only have something to add but can also leave with some useful nugget from that conversation to use elsewhere.

I’m not alone — and talking to my historian colleague Margaret, I get the impression that this really isn’t all that new. When Johnson & Johnson started back in 1886, conversations occurred all the time between the company, its customers and the community. We’ve both found that blogs can be a way for us to go back to the future to reengage with people and hear what we’ve been missing. And I’m delighted to have been joined by some of my colleagues at Johnson & Johnson in more recent postings on JNJBTW.

Alas. Though we’re trying, we still have to get better at listening.

Read More

September 25th, 2007

Sharing the Learning Curve

I have only been a part of Johnson & Johnson since the beginning of the year, and so I get questions from my friends and family all the time about what it is like now to be working at Johnson & Johnson, “the baby company.” This question is usually followed by a request for baby lotions, beauty products or Band-Aid Brand adhesive bandages.

It can be a steep learning curve coming into Johnson & Johnson and getting up to speed on its many businesses, but as I learn things I hope to share some of my observations with you. I want to provide a voice on JNJBTW that brings a bit of an “outsider’s” perspective.

Johnson & Johnson is no different than most companies in the fact it faces sizable business challenges every day. For example, as a health care company with a pharmaceuticals business, we have to deal with how to replace significant revenues from drugs that will be going off patent and how to handle unprecedented reimbursement challenges for drugs like erythropoiesis-stimulating agents (speaking of my learning curve…).

There is a healthy curiosity and a natural skepticism in the marketplace about how companies, including Johnson & Johnson, can overcome such challenges.

Read More

May 2nd, 2016

A Message About Talc

JOHNSON’S<sup>®</sup> Baby Powder30 years of studies by medical experts around the world, science, research and clinical evidence continues to support the safety of cosmetic talc. We first offered JOHNSON’S® Baby Powder as a product choice more than 100 years ago because we were confident in the safety of talc. And today, we continue to manufacture and sell JOHNSON’S® Baby Powder with talc because we remain completely confident in its safety. We remain committed to safety and innovation, and will continue to work hard to exceed consumer expectations and evolving product preferences. This commitment to innovation led to the introduction of JOHNSON’S® Baby Powder made with cornstarch as an additional option for consumers nearly forty years ago.

Everyone at Johnson & Johnson sympathizes deeply with the women and families who have been affected by ovarian cancer, a devastating disease with no known cause. We know the women and families affected are searching for answers and want to understand the science.

Safety

When concerns about an association between talc and ovarian cancer were first raised in the early 1980s, Johnson and Johnson took them very seriously and did the things you expect from a company you trust including:

  • Testing to ensure that the talc in JOHNSON’S® Baby Powder meets the highest Quality standards (US Pharmacopeia),
  • Engaging with the FDA, regulatory agencies, and governments around the world
  • Monitoring studies and all available information examining the safety of talc
  • Talking with independent consultants from outside our company about their point of view on the safety of talc.

Read More

April 29th, 2016

The Chewable Pill That Could Help Save Millions of Children Worldwide

By William Lin, Director, Neglected Tropical Diseases, Johnson & Johnson Global Public HealthMebendazole News

Mebendazole News

A new, chewable version of mebendazole makes it easier to treat intestinal worm infections in children.
PHOTO CREDIT: Shutterstock

Soil-transmitted helminthiasis (STH), otherwise known as an intestinal worm infection, affects around two billion people worldwide—that’s over a quarter of the global population.

I have seen firsthand how this neglected tropical disease impacts the most underserved and vulnerable communities, especially in developing countries with limited clean water or sanitation.

STH afflicts both adults and children. However, kids are more greatly affected because infections during the formative developmental periods of their lives can lead to malnutrition, anemia, stunted growth, and even death. More than 800 million children live in endemic areas in need of treatment and preventive interventions.

As part of our ongoing commitment to global public health, Janssen Pharmaceuticals—one of the Janssen Pharmaceutical Companies of Johnson & Johnson—has submitted a new drug application to the U.S. Food and Drug Administration (FDA) for approval of a chewable formulation of mebendazole, which is a single dose treatment for adults and children over the age of one who have STH.

What Makes This New Treatment So Unique

When mixed with a few drops of water, the chewable mebendazole tablet forms a soft mass, making it easier to treat STH in children too young to swallow a solid tablet.

Read More